NewEdge Advisors’s Cellebrite CLBT Stock Holding History

NewEdge Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$423	Hold	29	–	–	﹤0.01%	4081
2026 Q1	$400	Sell	29 -374	-93%	-$5.64K	﹤0.01%	4011
2025 Q4	$7.27K	Hold	403	–	–	﹤0.01%	3567
2025 Q3	$7.47K	Sell	403 -1	-0.2%	-$16	﹤0.01%	3415
2025 Q2	$6.46K	Sell	404 -3,386	-89%	-$60.4K	﹤0.01%	3338
2025 Q1	$73.6K	Sell	3,790 -120	-3%	-$2.53K	﹤0.01%	2399
2024 Q4	$86.1K	Buy	3,910 +3,352	+601%	+$64.5K	﹤0.01%	2324
2024 Q3	$9.4K	Buy	558 +374	+203%	+$5.55K	﹤0.01%	2959
2024 Q2	$2.2K	Buy	184 +154	+513%	+$1.72K	﹤0.01%	3315
2024 Q1	$332	Buy	+30	New	+$306	﹤0.01%	3629

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

NewEdge Advisors's CLBT Position: Q2 2026 in Review

NewEdge Advisors held its Cellebrite (CLBT) position steady in Q2 2026 at 29 shares worth $423. The position accounts for ﹤0.01% of the portfolio, ranked #4081.

NewEdge Advisors first reported a position in CLBT in Q1 2024 and has held it in 10 quarters since. The position peaked at $86.1K in Q4 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

NewEdge Advisors held 29 shares of Cellebrite worth $423 as of Q2 2026.
NewEdge Advisors left its Cellebrite share count unchanged in Q2 2026.
Cellebrite made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #4081 holding.
NewEdge Advisors first reported a position in Cellebrite in Q1 2024 and has held it in 10 quarters since.
NewEdge Advisors's Cellebrite position peaked at $86.1K in Q4 2024.
201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.